Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Atherosclerosis. 2011 May 27;217(2):441–446. doi: 10.1016/j.atherosclerosis.2011.05.022

Table 2.

Descriptive statistics of baseline characteristics and biomarker measurements in Troy participants, by race/ethnicity (N=768)

Asian
(N=161)
Black (N=38) Hispanic
White
(N=131)
Non-Hispanic
White
(N=345)
Other (N=93) p-value

Median IQR Median IQR Median IQR Median IQR Median IQR
Age 19.2 1.7 19.7 2.3 19.2 1.9 19.8 2.2 19.5 1.9 <0.0001
CIMT, µm 587.5 73.5 631.0 61.0 588.5 75.0 607.5 79.0 604.5 95.0 <0.0001
Height, cm. 165.0 14.0 170.5 14.0 168.0 13.0 172.0 13.0 169.0 14.0 <0.0001
Weight, lbs. 59.9 16.3 68.7 20.0 66.7 17.2 67.1 16.3 64.9 15.9 <0.0001
BMI, kg/m2 21.4 3.6 23.0 5.3 23.2 5.0 22.4 3.4 22.5 3.8 <0.0001
SBP, mmHg 104.0 13.0 109.0 12.0 107.0 14.0 109.0 11.0 107.0 12.0 0.0002
DBP, mmHg 58.0 7.0 60.5 11.0 57.0 8.0 57.0 9.0 58.0 7.0 0.08
CHOL (mg/dL) 165.0 37.0 148.5 35.0 158.0 40.0 156.0 38.0 153.0 33.0 0.02
TRIG (mg/dL) 72.0 39.0 51.0 21.0 72.0 48.0 74.0 44.0 67.0 36.0 <0.0001
HDL (mg/dL) 54.0 17.0 58.5 12.0 50.0 18.0 50.0 17.0 55.0 20.0 <0.0001
LDL (mg/dL) 93.0 30.0 81.5 32.0 90.0 31.0 89.0 34.0 83.0 32.0 0.08
CRP, mg/L 0.3 0.7 0.3 0.6 0.7 1.6 0.6 1.6 0.4 1.3 <0.0001
Insulin, mIU/mL 4.3 5.9 3.9 5.2 3.7 5.5 3.6 4.7 3.1 4.6 0.27
Homocysteine, mmol/L 6.1 2.3 6.2 2.4 5.9 2.3 6.1 2.1 5.8 2.1 0.31
Glucose, mg/dL 79.0 7.0 76.0 5.0 78.0 7.0 77.0 7.0 77.0 8.0 0.03
*

p-values are calculated from Kruskal-Wallis Test.

Min=Minimum value, Max=Maximum value, IQR=Interquartile range.

HHS Vulnerability Disclosure